pirfenidone
Commercial- Indications
- Idiopathic pulmonary fibrosis
Company intelligence / Profile preview
Jiangsu Wangao Pharmaceutical is an active Chinese pharmaceutical manufacturer focused on small molecule drugs, with a pipeline spanning neoplasms, metabolic/endocrine disorders, nervous system diseases, and urogenital conditions. The company has several clinical-stage assets and is involved in the development and manufacturing of both innovative and generic pharmaceuticals. It recently entered into agreements to transfer rights to certain products such as nintedanib to Gyre Pharmaceuticals.
3 more assets in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jiangsu Wangao Pharmaceutical Co., Ltd..